The Korea Times
BNCERA Aesthetic Medicine Congress 2026 in Incheon was a flashpoint for BNCERA CEO Jaha Zoda and his aesthetic medicine products company. More than 200 physicians, distributors and other industry professionals from 23 countries gathered at Paradise City Hotel from Monday to Friday to hear about the company’s latest breakthroughs. The event began a day after the company hosted an opening ceremony for its first Korean manufacturing plant in the city’s Namdong District, establishing a pipeline for the company’s product lineup under its Tesoro Pro signature brand including fillers, fat dissolvers and skin boosters. The congress gave a preview of BNCERA’s next-generation hyaluronic acid filler platform that is now in development. The new ATHEVA lineup is scheduled for market launch next year. Zoda said the platform’s technological strengths speak for themselves, citing controlled formulation, refined purity, predictable injection behavior and indication-oriented design, while dismissing the superlatives often used in filler marketing. “We kept asking one question during its develo
Go to News Site